Home > Financial Ratios > BIOCON
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 2.572.452.061.311.36

What is the latest Fixed Capital/Sales ratio of BIOCON ?

The latest Fixed Capital/Sales ratio of BIOCON is 2.57 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20252.57
Mar20242.45
Mar20232.06
Mar20221.31
Mar20211.36

How is Fixed Capital/Sales of BIOCON Trending?

Years Fixed Capital/Sales % Change
Mar2025 2.57
4.90
Mar2024 2.45
18.93
Mar2023 2.06
57.25
Mar2022 1.31
-3.68
Mar2021 1.36 -

Other Financial Ratios of BIOCON


Compare Fixed Capital/Sales ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹50,839.4 Cr 1.8% 8% 17.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,147.0 Cr -1.4% 3.6% -7.8% Stock Analytics
DIVIS LABORATORIES ₹180,488.0 Cr 4.4% 15.9% 15.6% Stock Analytics
CIPLA ₹121,452.0 Cr -4.9% -0.8% 6.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,057.0 Cr -0.6% 1.8% 15.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,220.0 Cr -4.1% -3.8% -4.3% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

1.8%

8%

17.6%

SENSEX

-1.4%

3.1%

3.8%


You may also like the below Video Courses